4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-010207
Options or other derivatives
- Director acquired 119,318 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
STALDER RUEDI · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-02-19 | Grant or award : show line 1 in the form Common Stock Options | +119,318 | $0.13 | 2023-02-19 | 119,318 | 1,918,339 | D |
Loading xslF345X03/form457960_20130220030315-.xml…